VERO BEACH, Fla., Sept. 8, 2026 /PRNewswire/ -- Watercrest Senior Living is proud to donate a community bus from Watercrest St. Lucie West Assisted Living and Memory Care to support local children during police raids, rescues and other crisis situations. The senior living bus will be transformed into a warm, welcoming and comforting space where children feel safe and cared for in challenging situations.

Bobi Kruemberg, Executive Director of Watercrest St. Lucie West, also serves as a board member for United Against Child Trafficking (UACT). During a recent meeting, Kruemberg learned of the critical need in the Port St. Lucie area for a mobile medical rescue unit to serve children in crisis situations. As Watercrest St. Lucie West had recently acquired another transport bus, Kruemberg spearheaded the donation of the bus with the Watercrest organization in full support.

"This project reflects a commitment to Watercrest's principles in serving a purpose greater than ourselves," says Marc Vorkapich, Principal and CEO of Watercrest Senior Living Group. "We are honored that a bus once used to serve our residents can now be repurposed to serve the critical needs of children in our community."

The bus renovation will require approximately $50,000 in materials and services, and the St. Lucie community has responded with an outpouring of generosity. A local craftsman recently volunteered to complete the exterior work, representing an estimated $15,000 donation to the project. Once renovated, the bus will feature a warm, inviting interior with cozy furnishings, soft blankets, and toys to provide a sense of security and reassurance when children are removed from challenging or unsafe circumstances.

"Our Watercrest residents and associates immediately understood the significance of this project," says Bobi Kruemberg, Executive Director of Watercrest St. Lucie West. "They are making blankets and donating toys for the bus so that every child can receive a gift blessed with love, prayers and the message that they are valued, protected and cared for."

Watercrest St. Lucie West is a signature Watercrest product providing 102 assisted living and 26 memory care apartments with resort-style service and breathtaking lakeside views. The community boasts an exquisite design with stunning promenade, fireplace, signature water wall, multiple dining options, pool, salon and spa, grand balconies and Florida style outdoor living spaces with picturesque water views. Watercrest St. Lucie West is conveniently located at 279 NW California Boulevard along Florida's breathtaking Treasure Coast, just minutes from abundant dining, entertainment, and retail options. For information, contact the community at 772-758-7472.

About Watercrest Senior Living Group

Watercrest Senior Living Group was founded to honor our mothers and fathers, aspiring to become a beacon for quality in senior living by surpassing standards of care, service and associate training. Watercrest senior living communities are recognized for their luxury aesthetic, exceptional amenities, world-class care, and innovative memory care programming offering unparalleled service to seniors living with Alzheimer's and dementia. A nine-time certified Great Place to Work, Watercrest specializes in the development and operations of assisted living and memory care communities and the growth of servant leaders. For information, visit www.watercrestseniorliving.com.

SOURCE Watercrest Senior Living Group

Share this article

Historic Midtown Manhattan Hotel Introduces Thoughtfully Redesigned Guestrooms and Corridors Anchored by Exclusive Artwork Curated in Partnership with The Al Hirschfeld Foundation

NEW YORK, Sept. 8, 2026 /PRNewswire/ -- The Algonquin Hotel, Autograph Collection, one of New York City's most storied literary landmarks, announces the completion of a full renovation of all guestrooms, elevators, and corridors, unveiling a reimagined residential experience that pays tribute to the hotel's legacy while opening a new chapter for this haven of creativity. Completed through a carefully phased, multi-year renovation process, the project was quietly executed while the hotel remained fully operational, preserving the guest experience throughout construction.

Led by Brooklyn-based interior design firm CRÈME / Jun Aizaki Architecture & Design in collaboration with LUCID, the design and development arm of leading hospitality management company Highgate Hotels, the redesign was guided by two central ideas: honoring The Algonquin's legacy and creating an ode to New York City. Drawing inspiration from the hotel's history as a gathering place for writers, performers, and academics, the refreshed guestrooms and corridors echo the hotel's long-standing irreverence and intimacy while channeling the layered creative energy of today's Manhattan.

"The Algonquin Hotel has long served as a safe haven for wild minds, a quiet place along Club Row in the center of the wonderful whirlwind that is New York City ", said Willis Loughhead, General Manager of The Algonquin, in his 6th year at the helm. "Our focus was to honor the past without being beholden to it; timeless rooms were built where creativity can be sparked, and our landmark charm will be enlivened."

Without altering the hotel's historic footprint, CRÈME leaned into the intimacy and scale of the guestrooms, embracing their proportions and allowing the original framework of the building to shape the experience. The result is a collection of layered, residential spaces designed to feel sophisticated and personal.

Each guestroom and suite is anchored by a custom triptych artwork featuring exclusive Al Hirschfeld pieces, curated in partnership with The Al Hirschfeld Foundation and Director David Leopold, including a gold leaf-accented Central Park illustration that is exclusive to The Algonquin Hotel. Throughout the corridors, visitors will discover archival Hirschfeld works spanning theater, music, literature and popular culture, with each floor featuring its own unique collection. The works selected were drawn from the entirety of Al Hirschfeld's 80-year career in New York City, with many of the pieces not publicly displayed in decades and others sourced exclusively from the Foundation's archives specifically for the hotel. Rather than presenting the artwork in a traditional gallery, the pieces are intentionally woven throughout the property to create a one-of-a-kind collection that encourages curiosity and conversation.

"The Algonquin and Al Hirschfeld share a uniquely New York story rooted in creativity, character and storytelling," said David Leopold of The Al Hirschfeld Foundation. "Together, the hotel and foundation curated a collection that can't be found anywhere else and an immersive experience where every hallway, room and detail invites guests to engage with art and storytelling in a deeply personal way."

The renovation also introduces unexpected design details such as oversized luggage-tag-inspired room signage featuring 181 individually curated quotes from legends who created or influenced the hotel. Each guestroom displays its own distinct message from a diverse cast of characters and past residents such as Kermit the Frog, Maya Angelou, John Leguizamo, The Notorious B.I.G., Dorothy Parker, and The Vicious Circle; all cultural figures with ties to The Algonquin Hotel Times Square and the city of New York City. Subtle Art Deco references and jazz-inspired patterns appear throughout the design, including rhythmic corridor carpeting that reflects the movement and improvisation of music while nodding to the era of the famed Algonquin Round Table.

Additional design details include brass fixtures, layered lighting, custom marble-topped furnishings inspired by the hotel's original stairwells and integrated architectural elements that enhance warmth and functionality throughout the historic building. Rich walnut woods, ebonized oak, aged bronze finishes, and plush charcoal velvet headboards create warmth within the rooms, while a palette of deep and light celadon, peacock green, charcoal, and soft neutrals evoke the charisma and comfort of past and present Manhattan.

The hotel's culinary experience has also evolved alongside the renovation, with new menu items and cocktails served alongside redesigned menus at The Blue Bar Restaurant & Lounge, also created in collaboration with The Al Hirschfeld Foundation. Featuring archival Hirschfeld drawings, the refreshed offerings extend the hotel's design narrative while honoring the artists, performers and personalities that have long shaped The Algonquin's cultural identity.

Since opening in 1902, The Algonquin Hotel has occupied a singular place within New York's cultural fabric, serving as both a refuge and meeting place for generations of literary, theatrical and creative figures. With the completion of its guestroom renovation, the hotel continues that legacy while creating space for a new generation of stories, conversations and discoveries to unfold. For more information on The Algonquin Hotel, visit www.algonquinhotel.com.

Images of Renovated Guest Rooms at The Algonquin Hotel HERE (Photo Credit: Michael Kleinberg, The Algonquin Hotel).

About The Algonquin Hotel, Autograph Collection:

Since opening its doors in 1902, The Algonquin Hotel has stood as a cultural landmark and one of New York City's most storied hotels. Just steps from Times Square and Fifth Avenue, the hotel has long been a gathering place for the city's literary and cultural elite. Most famously, the Algonquin Round Table of the 1920s brought together luminaries such as Dorothy Parker, Robert Benchley, Harold Ross, Alexander Woollcott, Franklin Adams, and Robert Sherwood — a circle of wit and intellect that helped shape American literature and journalism. It was within these walls that The New Yorker magazine was conceived, further cementing the hotel's place in cultural history. Today, the 181-room hotel continues to honor its timeless legacy while welcoming modern travelers to create stories of their own. Guests can enjoy refined dining at the Round Table Restaurant, handcrafted cocktails at the Blue Bar, and the hotel's distinctive blend of history, charm, and style. The Algonquin was recently inducted into Historic Hotels of America®, the official program of the National Trust for Historic Preservation recognizing the nation's most iconic historic hotels and named one of the Top 25 New York City Hotels by readers of Conde Nast Traveler. For more information, please visit www.algonquinhotel.com.

SOURCE The Algonquin Hotel, Autograph Collection

Share this article

Featuring Haley Van Voorhis, who made NCAA College Football History three years ago, the campaign drives home a simple truth; a healthy body and a healthy planet share the same foundation of preparation, restoration, and resilience.

THE PLAINS, Va., Sept. 8, 2026 /PRNewswire/ -- ACRE Investment Management, a leading natural capital investment platform, today launched Playbook for the Planet, a new campaign built around a simple idea: healthy people depend on a healthy environment.

At the center of the campaign is Haley Van Voorhis (instagram.com/haleyvanv), who made NCAA college football history in September 2023. Her journey in football reflects the preparation, persistence, and resilience required to challenge expectations and create lasting change.

Those same qualities have shaped ACRE's approach to restoring natural systems for more than two decades. Reforestation, oyster reef restoration, nutrient banking, and other nature-based solutions do not happen overnight. They require planning, teamwork, patient capital, scientific measurement, and long-term stewardship.

Playbook for the Planet brings these two stories together.

"Resilience is not built in the moment it gets tested. It is built long before anyone is watching," said Haley Van Voorhis. "As athletes, we depend on the air we breathe, the water we drink, and the outdoor places where we train, compete, and recover. Caring for those systems is part of caring for ourselves and the generations that come after us."

The campaign draws a connection between the environments that support human performance and the natural systems that sustain communities. Clean air, healthy soil, functioning waterways, forests, and coastlines are not distant environmental concepts. They are part of the places where people live, work, play, and recover.

For ACRE, that connection is grounded in years of work alongside landowners, foresters, scientists, conservation professionals, and community partners. Across the Mississippi Alluvial Valley, the Carolina Piedmont, and the Chesapeake Bay region, ACRE and its platforms have helped build the financial and operational infrastructure needed to restore nature at scale.

ACRE's work includes GreenTrees, a reforestation program covering more than 140,000 acres of privately owned land across approximately 650 landowner partners; Conservation+, a Virginia nutrient bank developer; Oyster Carbon Company, which advances oyster reef restoration in the Chesapeake Bay; and Big River Nursery, a producer of Eastern Cottonwood planting stock. Together, these efforts reflect a broader vision of natural capital that recognizes the interconnected value of air, land, and water.

"The trees, reefs, and restored landscapes are what people see, but every project begins with people," said Marcia Degnan, Chief Marketing Officer of ACRE Investment Management. "Behind the work are landowners making long-term decisions about their property, scientists measuring outcomes, nurseries growing the next generation of forests, and partners willing to invest in restoration. Playbook for the Planet is about telling that larger story and showing that the health of people and the health of the places around them are intertwined."

Rather than presenting conservation as something removed from daily life, Playbook for the Planet invites people to see themselves as participants. The choices made today about forests, waterways, coastlines, and working lands will shape the places where future generations live and play.

The campaign will share stories from athletes, landowners, restoration professionals, and others whose work demonstrates what long-term resilience looks like in practice. More information is available at acre-investment.com/playbook-for-the-planet.

About ACRE Investment Management

ACRE Investment Management, LLC is a natural capital company managing five platforms across carbon removal, reforestation, nutrient mitigation, and ecosystem restoration. ACRE works with private landowners, corporate buyers, investors, and government agencies to make large-scale restoration economically achievable. Follow on LinkedIn at https://www.linkedin.com/company/acre-investment-management.

About Haley Van Voorhis

Haley Van Voorhis is a former Shenandoah University football safety who made NCAA history in September 2023, recording a quarterback hurry that garnered international attention and led to her jersey and helmet being included in the NCAA College Football Hall of Fame. A multi-sport athlete, she also played for the D.C. Divas of the Women's Football Alliance. As the featured voice of Playbook for the Planet, Van Voorhis brings her commitment to preparation, perseverance, and resilience to the connection between human and planetary health.

Media Contact

Randy Williams

[email protected]

(917) 213-5980

SOURCE ACRE Investment Management

Share this article

Cell Stem Cell: Die tBE-vermittelte Base-Editing-Therapie erzielt bei unterschiedlichen genetischen Hintergründen eine dauerhafte klinische Remission bei Sichelzellkrankheit und β-Thalassämie

Nachdem bei chinesischen TDT-Patienten eine 100-prozentige Transfusionsunabhängigkeit erreicht wurde, bestätigt eine neue Studie, dass tBE für afrikanische SCD-Patienten sowie für TDT-Patienten aus Süd- und Südostasien ebenso sicher und wirksam ist.

SHANGHAI, 8. September 2026 /PRNewswire/ -- Am 7. September 2026 veröffentlichte Cell Stem Cell in Shanghai online eine klinische Forschungsarbeit von CorrectSequence Therapeutics (Correctseq), die in Zusammenarbeit mit mehreren Institutionen entstand, unter dem Titel „Clinical base editing for β-hemoglobinopathies across different genetic backgrounds" („Klinisches Base Editing bei β-Hämoglobinopathien mit unterschiedlichen genetischen Hintergründen"), wobei gezeigt wurde, dass CS-101/CS-206 – eine mit dem transformer Base Editor (tBE) entwickelte Base-Editing-Therapie – bei Patienten mit β-Hämoglobinopathien unterschiedlicher genetischer Herkunft eine gleichbleibende Wirksamkeit und Sicherheit erzielte. Dies knüpft an den früheren klinischen Bericht des Teams über fünf chinesische Patienten mit transfusionsabhängiger β-Thalassämie (TDT) an, die mit CS-101 behandelt wurden und alle die Transfusionsunabhängigkeit erreichten (Lai et al, Nature, 2026). Die neue Studie weitet die Behandlung auf vier weitere Patienten aus Nigeria, Laos, Malaysia und Pakistan aus – einen mit Sichelzellkrankheit (SCD) und drei mit TDT. Alle erreichten eine rasche hämatopoetische Rekonstitution, eine anhaltend hohe panzelluläre HbF-Expression, vollständige Transfusionsunabhängigkeit oder Freiheit von vaso-okklusiven Krisen (VOCs), ohne nachweisbare Off-Target-Edits oder produktbedingte unerwünschte Ereignisse.

Breite Anwendbarkeit bei verschiedenen ethnischen Gruppen und Mutationen

β-Hämoglobinopathien gehören zu den häufigsten monogenen Erkrankungen; weltweit sind jährlich über 300 000 Neugeborene von SCD und über 40 000 von TDT betroffen. Pathogene Mutationen variieren erheblich zwischen den Populationen. Das Team hatte zuvor den ultrapräzisen tBE (Wang et al., Nat Cell Biol, 2021) entwickelt, um die HBG1/2-Promotorregion in autologen, den Patienten entnommenen HSPCs präzise zu editieren und so die γ-Globin-Expression wieder zu aktivieren. Die Genotypen der vier Patienten in der vorliegenden Studie umfassten βS/βS bei SCD sowie drei TDT-Genotypen – β⁰/βᴱ, β⁰/β⁰ mit einer großen Deletion und β⁰/β⁰ mit einer Einzelnukleotid-Insertion –, was die universelle Anwendbarkeit der Strategie bestätigt.

Klinische Daten: Rasches Engraftment, anhaltendes Ansprechen, vollständige Transfusionsunabhängigkeit und keine Off-Target-Mutationen

Bei der 21-jährigen SCD-Patientin aus Nigeria, bei der im Jahr vor dem Studieneinschluss mehr als vier VOCs aufgetreten waren, wurde das Neutrophilen-Engraftment an Tag 13 und das Thrombozyten-Engraftment an Tag 21 nach der Infusion erreicht. Der Gesamt-Hämoglobinspiegel stieg von 7,7 g/dl zu Studienbeginn auf 12,9 g/dl im dritten Monat an und blieb über 11 g/dl; der HbF-Spiegel stieg von 3,5 % auf 62,2 %, während der HbS-Spiegel von 76,1 % auf 31,6 % sank und sich bei einem Verhältnis von etwa 6:4 stabilisierte. Nach einer Nachbeobachtungszeit von 15,5 Monaten traten keine VOCs auf.

Bei den drei TDT-Patienten (im Alter von 3 bis 29 Jahren, aus Laos, Malaysia und Pakistan) wurde nach 13 Tagen das mediane Neutrophilen-Engraftment und nach 27 Tagen das mediane Thrombozyten-Engraftment erreicht. Die mittlere Gesamt-Hämoglobinkonzentration lag bei 11,6 ± 1,2 g/dl, und die mittlere HbF-Konzentration stieg im dritten Monat auf 9,8 g/dl an. Nach einer medianen Nachbeobachtungszeit von 17,5 Monaten hatten alle Patienten eine dauerhafte Transfusionsunabhängigkeit erreicht. Es wurden keine Off-Target-Veränderungen oder produktbedingten unerwünschten Ereignisse festgestellt.

Vergleich mit nukleasebasierten Gen-Editing-Therapien: Schnelleres Engraftment, höhere Expression, höhere Sicherheit

In klinischen Studien zur SCD erzielte tBE ein überlegenes Neutrophilen-Engraftment (13 Tage) gegenüber Cas9 (27 Tage) und Cas12a (23 Tage) sowie ein überlegenes Thrombozyten-Engraftment (21 Tage) gegenüber Cas9 (35 Tage) und Cas12a (25 Tage). tBE hielt einen HbF-Anteil von >60 % des gesamten Hämoglobins aufrecht und übertraf damit die Cas9- und Cas12a-Behandlungsschemata (50 %) deutlich.

Im Gegensatz zu Nukleasen, die auf DNA-Doppelstrangbrüche (DSBs) angewiesen sind, ermöglicht tBE eine präzise Basenumwandlung, ohne die DNA zu spalten, wodurch die Aktivierung von p53, Apoptose, große Deletionen und chromosomale Umlagerungen vermieden werden. Sein duales gRNA- und „Schlüssel-Schloss"-Design minimiert das Risiko von Off-Target-Effekten zusätzlich. Durch ein spaltbares „Schloss" wird tBE nur an den Zielstellen aktiviert, wodurch eine hocheffiziente Editierung bewirkt wird. Bei der Bindung an Off-Target-Stellen blieb tBE „gesperrt", um Off-Target-Mutationen zu vermeiden.

Weltweite Fortschritte und regulatorischer Zulassungsweg

Bislang wurden mit CS-101 und CS-206 mehr als 30 Patienten in China, Afrika, Südostasien und Südasien behandelt, wobei 100 % der Patienten Transfusionsunabhängigkeit erreichten oder frei von VOCs blieben und eine anhaltend hohe Hämoglobinexpression aufwiesen. CS-101, der weltweit erste in klinischer Entwicklung befindliche Base-Editing-Therapiekandidat, dessen erster Patient im Oktober 2023 behandelt wurde, hat Phase I abgeschlossen und wird derzeit in zulassungsrelevanten Studien untersucht. Alle in Phase I behandelten Patienten sind seit mehr als einem Jahr transfusionsunabhängig, wobei die längste Dauer fast drei Jahre beträgt.

Professor Chen Jia, Gründer von Correctseq und Direktor des Gene Editing Center an der ShanghaiTech University, erklärte: „Dieser Artikel in Cell Stem Cell bestätigt die breite Anwendbarkeit von tBE bei unterschiedlichen genetischen Hintergründen und schließt damit den Weg von der Laborforschung zur weltweiten klinischen Anwendung ab. Unser Team befasst sich außerdem mit RNA-Editing, Prime-Editing und mitochondrialem DNA-Editing für andere Therapiebereiche."

Dr. Mou Xiaodun, Geschäftsführer von Correctseq, fügte hinzu: „Die Daten belegen, dass tBE eine weltweit führende Plattform ist. Darüber hinaus erweitern wir unser Tätigkeitsfeld auf Stoffwechsel- und Herz-Kreislauf-Erkrankungen, darunter Hypertriglyceridämie/familiäres Chylomikronämie-Syndrom (FCS), ASCVD/Hyperlipoproteinämie, homozygote familiäre Hypercholesterinämie (HoFH) sowie Metabolische Dysfunktion-assoziierte Steatohepatitis (MASH). Wir treiben mehrere Entwicklungsprojekte voran, um weltweit IND-Anträge einzureichen und so die in China entwickelte Geneditierung mehr Patienten weltweit zugänglich zu machen."

Link zum Artikel in Cell Stem Cell: https://doi.org/10.1016/j.stem.2026.08.009

Informationen zu CorrectSequence Therapeutics

CorrectSequence Therapeutics (Correctseq) ist ein Biotechnologieunternehmen in der klinischen Entwicklungsphase, das seinen firmeneigenen „transformer Base Editor (tBE)" einsetzt, um wegweisende Gen-Editierungs-Therapien der nächsten Generation zu entwickeln. Das Unternehmen hat mehrere hochmoderne Base-Editing-Systeme entwickelt, die außergewöhnliche Präzision bieten, Off-Target-Effekte minimieren und die Editierungseffizienz ex vivo und in vivo verbessern. Die umfangreiche Pipeline des Unternehmens umfasst genetische Erkrankungen, Stoffwechselerkrankungen und Herz-Kreislauf-Erkrankungen, wobei sich mehrere Programme bereits auf dem Weg in die klinische Entwicklung befinden.

Weitere Informationen finden Sie auf www.correctsequence.com.

Danksagungen: The First Affiliated Hospital of Guangxi Medical University, ShanghaiTech University, Children's Hospital of Fudan University, Institutes of Biomedical Sciences, Fudan University, Shanghai Clinical Research and Trial Center.

Medienkontakt:

Geschäftliche Zusammenarbeit: [email protected]

Rekrutierung für klinische Studien: [email protected]

Share this article

Disruptive Science, AI, and Innovation Forum at Clinton Presidential Center

Free Admission to Learn About Prevention, Transplants, and Treatments

WASHINGTON, Sept. 8, 2026 /PRNewswire/ -- The American Association of Kidney Patients (AAKP), the nation's oldest and largest fully independent kidney patient advocacy organization, will host its 51st annual National Patient Meeting September 10 – 13, 2026, in Little Rock, Arkansas. Event admission and meals are free to kidney patients, family members/care partners, and living organ donors; pre-registration is encouraged and can be completed online at https://bit.ly/AAKPNPM or by calling (800) 749-2257.

In 2011, AAKP hosted a ground-breaking policy forum at the William J. Clinton Presidential Center that highlighted the direct link between outdated, status quo kidney dialysis care and patient unemployment. This marked the first time a national kidney group had targeted increased medical innovation and policy advocacy specifically as a strategy for ending economic dependency and increasing patient survival.

The 2026 AAKP National Patient Meeting is the premier in-person and online kidney patient and care partner event and a key element of AAKP's Decade of the Kidney™ initiative. More than 30 expert speakers are involved in the 2026 Little Rock program including kidney professionals, healthcare and policy influencers, advocacy skill trainers, innovation leaders from pharmaceutical, device, and diagnostic companies, and nonprofit executives. The meeting follows AAKP's successful All Kidney Policy is Local™ national campaign which connected patients, organ donors, and caregivers to U.S. Congressional leaders in their home district offices and online during the Congressional summer recess. The campaign has resulted in over 300 targeted legislative and policy meetings with top Congressional decision-makers since 2025.

Featured experts from the University of Arkansas for Medical Sciences (UAMS) include Dr. John M. Arthur, Chief, Nephrology Division; Director, Translational Research Institute; and Director, Junior Faculty Mentored Research Program, Department of Internal Medicine, UAMS; Dr. Brandi P. Wright, Nephrologist, Jefferson Regional Medical Center; Medical Director, Lifepoint Health Systems; Associate Professor, UAMS; Dr. Manisha Singh, Professor; Director, Home Dialysis, UAMS and VA Little Rock; Co-Director Renal Module, Division of Nephrology, Department of Internal Medicine, UAMS, and Joy Cope, MSN, MBA-HC, RN; Nursing Director & Administrator, Solid Organ Transplant Program, UAMS.

Dr. Arthur will speak on Cardio Kidney Metabolic (CKM) Syndrome; Dr. Wright will speak on Cardio Kidney Metabolic (CKM) lab values; Dr. Singh will speak on rare kidney diseases; and Ms. Cope will discuss how kidney patients maintain transplant readiness and eligibility. They are joined by internationally recognized known science leaders and clinicians Dr. Dominic Raj, the Bert B. Brooks Chair in the School of Medicine, Professor of Medicine, Biochemistry and Genetics and Biostatistics and Epidemiology and Director of the Division of Renal Disease and Hypertension at the George Washington University School of Medicine and Health Sciences (GW SMHS) and Dr. Prabir Roy-Chaudhury, the Drs. Ronald and Katherine Falk Eminent Professor in Nephrology and the Co-Director of the Kidney Center at the University of North Carolina (UNC). Drs. Raj and Roy-Chaudhury will discuss rapidly evolving kidney science and new, transformative kidney care innovations.

The AAKP National Patient Meeting begins Thursday, September 10, with AAKP's Public Policy Forum at the William J. Clinton Presidential Center from 1:00 p.m. – 4:00 p.m. CT. This complimentary, in-person event will highlight kidney research and innovation and the impact of federal regulatory and reimbursement decisions. Doors open at 12:00 p.m. CT with lunch provided. Registration is required, please click here to reserve your spot.

The National Patient Meeting continues September 11 – 13 at the Little Rock Marriott. Click here for virtual registration, and here for in-person registration.

Who: The American Association of Kidney Patients (AAKP)

What: The 51st Annual National Patient Meeting

When: September 10-13, 2026

Where: Public Policy Forum, September 10th from 1:00 p.m. – 4:00 p.m. CT at the Clinton Presidential Library (free registration, complimentary lunch provided); National Kidney Patient Meeting, September 11 – 13 at the Little Rock Marriott, Little Rock, Arkansas, and virtually (free registration for virtual and in-person attendees, complimentary meals provided to in-person attendees)

Follow AAKP on social at @kidneypatient on Facebook, @kidneypatients on X, and @kidneypatients on Instagram. Visit http://www.aakp.org for more information on AAKP patient leadership and kidney care.

MEDIA CONTACT:

Brendan LaCivita

National and Medical Media Specialist

[email protected]

(813) 906-7740

SOURCE American Association of Kidney Patients

Share this article

Quva and CAPS collaborate to maintain supply of critical medications to U.S. hospitals.

SUGAR LAND, Texas and ALLENTOWN, Pa., Sept. 8, 2026 /PRNewswire/ -- QuVa Pharma, Inc. ("Quva") and Central Admixture Pharmacy Services, Inc. ("CAPS") today announced that Quva has acquired a range of essential medications from CAPS following CAPS' decision to exit the 503B sterile compounding business. Quva expects to begin introducing selected products from the acquired portfolio in phases later in 2026 and to expand its offerings over the following six (6) months.

"We are proud to work with Quva, a recognized leader in 503B outsourcing manufacturing, to help ensure continued access to a number of essential medications," said Michael Parden, Chief Executive Officer of B. Braun of America. "Products such as Cardioplegia, Neonatal Starter Bags and Heparin play an important role in patient care, and this transition supports continuity of supply for the patients and providers who depend on them. We also appreciate Quva's commitment to providing employment opportunities for CAPS colleagues currently supporting our local 503B sterile compounding operations."

Operating from more than 200,000 sq. ft. of FDA-registered 503B manufacturing facilities in New Jersey and Texas and 100,000 sq. ft. of forward distribution centers in Texas and Arizona, Quva serves more than 3,500 hospitals and health system customers nationwide with its broad portfolio of sterile compounded medications manufactured under rigorous quality standards.

"We appreciate the opportunity to partner with CAPS to maintain the supply of these critical medications," said Stuart Hinchen, Chief Executive Officer of Quva. "Health systems depend on prepared medications that are essential to patient care but difficult to produce reliably at scale. This acquisition reflects our commitment to investing in the specialized products, manufacturing capabilities, quality systems, distribution infrastructure, technology, and people needed to support these critical medication categories. We look forward to working with CAPS and our health-system customers to maintain supply and build more dependable solutions for the future."

About Quva

Quva helps health systems address critical medication needs across the enterprise. Through two distinct businesses, Quva supports both the supply of essential prepared medications and the use of complex medication data to improve enterprise decision-making.

Quva Pharma partners with hospitals and health systems to support categories of ready-to-administer and compounded medications that are essential to patient care and difficult to prepare reliably at scale.

Quva BrightStream connects and normalizes medication data from more than 400 source systems across sites of care, helping health-system leaders identify what matters, understand why, and make better decisions.

Together, Quva's businesses share a commitment to helping health systems deliver safe, dependable, and effective medication care.

For more information, visit onequva.com.

About B. Braun

B. Braun Medical Inc. (B. Braun) is a leader in smart infusion therapy and safe and effective pharmacy products, patient and provider safety, and sustainable health solutions. Our purpose is to help providers constantly improve patient satisfaction and outcomes. With products and services created to help healthcare professionals focus on what matters most—their patients—we're uniquely positioned to help health systems succeed now and in the future. B. Braun is headquartered in Bethlehem, Pennsylvania and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®. The company employs 8,500 people at over 30 locations across North America.

Globally, the B. Braun Group of Companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, explore our website.

SOURCE B. Braun Medical Inc.

Share this article

Award-winning campaign offers more than $30 in Deals for a Limited Time

CINCINNATI, Sept. 8, 2026 /PRNewswire/ -- Penn Station Sandwiches, recently rebranded from Penn Station East Coast Subs, is providing guests a delicious way to save while giving back to the community, with the return of its annual Deals for Down Syndrome fundraising campaign.

For a limited time, while supplies last, guests donate $5 to receive a coupon booklet packed with over $30 in Penn Station offers, with proceeds benefiting Down Syndrome Associations across the country. Penn Station Sandwiches matches every dollar raised, doubling the impact of customer donations.

"Year after year, our guests show us just how much they care about supporting their communities," said Jeff Osterfeld, founder of Penn Station Sandwiches. "Surpassing $2 million in support is something we're incredibly proud of, but what matters most is the impact those dollars can have for individuals with Down syndrome and their families. We're grateful to everyone who purchases a booklet and makes a donation or helps us spread the word."

The Deal: (Photo Here)

Available at participating Penn Station locations, the Deals for Down Syndrome booklet features four coupons that guests can use on future visits including:

- FREE small sub or sandwich

- FREE kid's meal with qualifying purchase

- FREE regular drink and small fry

- BUY ONE, GET ONE FREE sub of equal value, any size

Each coupon includes a unique, one-time-use promotional code and can be redeemed in-store, online or through the Penn Station app through March 21, 2027—National Down Syndrome Awareness Day.

"Our long-standing partnership with Penn Station means so much to the Down syndrome community," said Beth Smith, Executive Director of the Down Syndrome Association of Greater Cincinnati. "It's incredibly meaningful to see Penn Station and its guests come together year after year to support individuals with Down syndrome and their families. This campaign not only raises important funds for local programs and resources but also helps bring greater awareness to the Down syndrome community. We're grateful for Penn Station's continued dedication and excited to build on that impact again this year."

Proceeds from Deals for Down Syndrome stay local, supporting Down Syndrome Associations in communities where Penn Station restaurants operate. These organizations provide programs, educational resources, advocacy and enrichment opportunities for individuals with Down syndrome and their families.

Save, Give Back and Get Rewarded

Guests can purchase a Deals for Down Syndrome booklet at a participating Penn Station restaurant or online while supplies last and then redeem their coupons in-store, online or through the Penn Station app.

To find a nearby Penn Station Sandwiches restaurant or place an order online, visit penn-station.com and join the conversation on Facebook https://www.facebook.com/pennstation and Instagram https://www.instagram.com/pennstationeastcoastsubs/.

About Penn Station Sandwiches 

Founded in 1985 by Jeff Osterfeld, Penn Station Sandwiches is celebrating over 40 years of serving award-winning grilled hot and classic cold subs, sandwiches, wraps, bowls and award-winning fresh cut fries complemented with freshly squeezed lemonade. Privately held and headquartered in Cincinnati, Ohio, the brand is known as a community staple in states including Ohio, Indiana, Kentucky, and Pennsylvania, while rapidly expanding into North Carolina, South Carolina, and Michigan. With more than 300 locations nationwide, Penn Station is considered among the country's strongest franchise systems and is proud to be ranked on the Entrepreneur Franchise 500 list.

Learn more about Penn Station Sandwiches at penn-station.com

About the Down Syndrome Association of Greater Cincinnati:

The mission of the Down Syndrome Association of Greater Cincinnati is to empower individuals, educate families, enhance communities and together, celebrate the extraordinary lives of people with Down syndrome.

Media Contact:

Lu Dumas

[email protected]

954.893.9150

SOURCE Penn Station Sandwiches

Share this article

Foodservice has transformed, but disposables haven't kept pace. Virginia manufacturer challenges foodservice industry to raise healthier standards: What touches your food should be worthy of it.

RICHMOND, Va., Sept. 8, 2026 /PRNewswire/ -- Virginia-based foodservice disposables manufacturer Terravive unveiled a new brand and mission built around "Worthy of Your Food," a direct challenge to the foodservice industry to rethink what touches our food. Current independent research is revealing an uncomfortable truth: conventional foodservice disposables are a hidden source of toxic exposure. Scientists at leading institutions, including NYU Langone, have documented that microplastics and nanoplastics are now present throughout the human body: in the brain, bloodstream, and placenta. Of roughly 16,000 chemicals used in plastic materials, about 4,000 are known to be toxic.

"We spend enormous energy asking what's in our food. We read labels. We worry about pesticides," said Julianna Keeling, founder and CEO of Terravive. "But then we put that carefully chosen food onto a toxic disposable container without thinking. The research is clear: what touches food matters to our health."

For years, foodservice has prioritized cost above all else. But research now demands a shift to human health. PFAS "forever chemicals" used in conventional foodservice disposables, have been linked to serious health concerns. Twelve states have already restricted PFAS in foodservice disposables, and Virginia's foam container ban extended to all foodservice businesses on July 1, 2026.

"Foodservice operators aren't asking these health questions because it's trendy," said Joe Swider, COO and U.S. Navy Veteran. "When you know microplastics are in human tissue, you can't ignore what your food is touching."

Terravive manufactures plant-based, compostable products from materials grown by local farmers, with no PFAS added and its products will not create microplastics. Critically, production happens across 16 U.S. facilities, giving direct control over materials, processes and a secure supply chain.

"American manufacturing isn't nostalgia. It's vital and reliable," Swider said. "When you control your manufacturing, you have greater ownership of your quality, lead time and pricing. Think about it, should your disposable fork have to travel 7,000 miles to get to you?"

Terravive believes healthier is possible. The company is building a future where foodservice disposables are worthy of the food they serve, the people who use them, and the communities they support.

About Terravive:

- Terravive was founded in 2015 by biomaterials chemist, Julianna Keeling and is a woman, minority and veteran-owned company.

- Manufactures 120+ plant-based, certified compostable foodservice disposables free from added PFAS and microplastics.

- Terravive's products are grown locally by American farmers and manufactured in the USA.

Learn how Terravive is rethinking foodservice disposables: www.terravive.com

SOURCE Terravive LLC

Share this article

TCL remporte plus de 30 distinctions internationales à l'IFA 2026, récompensant ses innovations de pointe dans les domaines de l'affichage, de l'intelligence artificielle et de la maison connectée

BERLIN, 8 septembre 2026 /PRNewswire/ -- TCL, leader mondial de l'électronique grand public et numéro un mondial des téléviseurs Mini LED et ultra-large[1], a annoncé avoir remporté plus de 30 distinctions lors de l'IFA 2026, dont sept mentions « IFA Innovation Award Honoree » et cinq « Global Product Technology Innovation Awards ». Les prix IFA s'ajoutent à de nombreuses distinctions décernées par des médias de référence dans le domaine de la technologie, notamment Android Authority, TechRadar, Tom's Guide et What Hi-Fi ?.

En tête de cette gamme primée, le téléviseur TCL X11L SQD-Mini LED a remporté à la fois l'IFA Breakthrough 2026 Award décerné par Android Authority et le Best in Show Award décerné par Tom's Guide lors de l'IFA 2026, récompensant ainsi sa technologie SQD-Mini LED de nouvelle génération. Le téléviseur TCL C8L SQD-Mini LED a reçu la distinction IFA Innovation Awards Honoree pour sa technologie d'affichage de pointe et son design raffiné. Le TCL X3 Series OLED + moniteur de jeu ont également reçu la distinction Honoree pour son contraste ultra-élevé, ses fréquences de rafraîchissement et son superbe design. Dans la catégorie des smartphones, au premier plan de laquelle le modèle phare P80 Ultra, le TCL P80 Series ultra-fin a remporté le Best of IFA 2026 Award décerné par Android Authority, une distinction spéciale ayant été décernée au P80 Ultra dans le cadre des IFA Innovation Awards pour son système photographique, son écran et son design, tous à l'avant-garde de leur catégorie. Dans la catégorie des lunettes connectées, le modèle RayNeo iO a remporté le prix IFA Innovation Award Honoree pour son assistant IA intégré, tandis que le modèle RayNeo GT Max AR a décroché à la fois le prix IFA Innovation Award Honoree et le Global Product Technology Innovation Award pour son expérience de réalité augmentée certifiée Dolby Vision, une première mondiale.

L'innovation de TCL s'étend à l'ensemble de la maison connectée grâce à une gamme de produits de plus en plus axés sur l'intelligence artificielle. Le climatiseur TCL Solar Series , le réfrigérateur TCL TwinMag Prime Fresh Series et le robot compagnon familial TCL heyAiMe ont chacun reçu un Global Product Technology Innovation Award, tandis que le routeur TCL 5G AI CPE X5 a reçu une distinction IFA Innovation Award Honoree pour ses fonctionnalités agentiques exhaustives.

Outre l'innovation en matière de produits, TCL contribue à faire évoluer les normes industrielles. TCL et TÜV Rheinland ont publié conjointement le livre blanc intitulé SQD-Mini LED Display Industry qui présente un cadre systématique permettant d'évaluer les performances des écrans dans diverses situations de visionnage réelles. TCL a également obtenu la première certification mondiale SGS Natural Light Visual Comfort, basée sur une norme élaborée en collaboration avec SGS. Ensemble, ces récompenses, certifications et initiatives sectorielles soulignent l'engagement global de TCL en faveur du développement des technologies de nouvelle génération et de l'intégration d'expériences plus intelligentes et plus intuitives dans la vie quotidienne.

À propos de TCL

TCL est une marque d'électronique grand public de premier plan et un leader mondial du secteur de l'équipement de télévision. Présente sur plus de 160 marchés dans le monde, TCL est spécialisée dans la recherche sur l'électronique grand public ainsi que dans le développement et la fabrication de produits connexes : téléviseurs, systèmes audio, appareils électroménagers, appareils mobiles, lunettes connectées, écrans commerciaux, etc.

Share this article

- AI's impact on corporate profit pools will more than triple the Internet's—in half the time

- Productivity gains get headlines today, but 75% of the opportunity and disruption lies beyond these, in innovation and competitive shifts

- AI will structurally transform 71% of sectors, versus 41% for the Internet—reaching industries the Internet never touched, with far-reaching consequences

NEW YORK and SAN FRANCISCO, Sept. 8, 2026 /PRNewswire/ -- AI puts $4.7 trillion of the profits of global business at stake between now and 2035 as its far-reaching impact drastically reshapes the global economy. In-depth Bain & Company analysis maps for the first time how AI is reorganizing whole industries and will create a wave of winners and losers across sectors as companies battle to seize the technology's potential.

Bain's calculation of the $4.7 trillion of profits put at stake by AI captures the scale of the business battleground confronting CEOs over the decade. It dwarfs even the $1.4 trillion of profit shifts over 20 years from the advent of the Internet, the last great technology disruption. In only half that time, AI will have more than triple the economic impact, reaching 1.7 times more widely, with 71% of sectors confronting structural transformation, versus 41% for the Internet, Bain reports.

Across 92 individual sectors, Bain's study charts the seismic shifts already taking place in industries' profit pools as AI use rapidly expands. It lays out the driving forces and breaks down which sectors will be most disrupted as the technology, and how CEOs respond, shapes a global business landscape of leaders, laggards, and losers.

"The $4.7 trillion profit pool shift is real, revolutionary, and already well underway. This is why, whatever sector companies are in, their CEO needs a clear prediction of where the industry is headed and a board-level commitment to act on it," said Dunigan O'Keeffe, partner in Bain & Company's Strategy & Transformation practice and lead author of the report. "Speed matters more than most CEOs realize. Move early and each deployment leaves you smarter than the last, with more data, workflows rewired around AI, and results that keep improving . None of that is for sale, so the company two years behind cannot buy its way back. The work is to figure out of what will matter in your industry a decade from now. Get that right and moving fast stops being a risk."

AI transformation is reaching the parts the internet didn't reach

Understanding the transformation underway, and who the winners and losers will be, requires a clear view of how technology disruptions work and what makes the AI revolution different, the report notes.

AI's fast-advancing restructuring of knowledge work, combined with its imminent impact on physical production through AI embodied in robots, means it will soon affect most of what the global economy does, Bain concludes. Its reach will extend into the high-value core of industries like industrial manufacturing, healthcare delivery, and pharmaceutical R&D that the Internet left untouched.

The Internet was chiefly a distribution technology that collapsed companies' costs to reach customers, but AI is a production technology that collapses the cost of producing goods and services themselves, not just how they are delivered, Bain says. It will have far greater impact as a result.

The forces behind the profit shifts: productivity gains, innovation, and market share shifts

Three driving forces underlie the $4.7 trillion shift in companies' profit pools over the next decade, Bain finds.

Productivity gains: Much of the focus on AI today is about productivity gains, and with good reason: Beyond the benefits reaped by consumers from better or cheaper products, companies will keep about $1.1 trillion in new profits as AI makes existing work cheaper, faster, and more scalable. Yet those gains represent just 24% of the total profit pool shift. Roughly 75% lies beyond productivity, in gains from innovation and market share shifts.

New innovation: Innovation among incumbents and new AI-enabled categories will generate $2.2 trillion in new profits (at 47%, the largest share of the total shift). New players will emerge, as they did in the Internet era, but AI offers incumbents opportunities to innovate in their core business across a much broader swath of the economy than the Internet did. AI will pull much of the rest of the economy into the digital world.

Market share shifts: $1.3 trillion of the shift will result from an extensive redistribution of existing profits between competing businesses as AI upends who can compete best, what cost structures work, and what capabilities matter. For many CEOs, the biggest risk and opportunity will be figuring out how to use AI better than their existing competitors.

Mapping the AI battlegrounds

Productivity gains, innovation, and market share shifts will play out unevenly across industries, Bain finds, but CEOs can build conviction about the implications of AI for their industry by understanding where their industry falls in one of four clusters.

Technology Foundation – demand is unavoidable, growth is explosive: in this cluster, with $1.5 trillion of profits in play, demand explodes because every other sector's AI adoption is unavoidable and non-negotiable. As every industry adopts AI, explosive demand follows for cloud infrastructure, data centers, semiconductors, mobile devices, PCs and servers, and AI foundation models, as well as the energy and physical infrastructure that powers and supports it all.

Rewired – an open race, the swift will win: in this cluster, with $1.5 trillion of profits at stake, Bain identifies a battleground in which AI will rapidly rewire competitive advantage in the affected industries, with a leadership gap between fast and slow AI adopters opening up within a few years, rather than decades and profit pools being fundamentally rebuilt.

In this "Rewired" cluster, leading incumbent companies that move fast to adopt AI will entrench their position as their data, regulatory, and scale advantages allow them to control profit pool shifts and capture disproportionate value. Incumbents who hesitate will cede value. Leaders will reinforce their position in sectors such as pharma and biotech, life sciences, healthcare delivery, healthcare equipment, aerospace and defense, and payments in financial services.

Yet other sectors in this 'Rewired' cluster will confront a wide-open race between established players and new entrants as AI erodes traditional boundaries and removes 'moats' for incumbents. Leadership in a sector then becomes a position to defend. And cost structures, workforce composition, and channel relationships may create drag for incumbents as AI-native competitors build competing models. These disruptions will mean there are no predetermined winners in sectors such as enterprise software, automotive manufacturing, advertising, consulting, corporate law, cybersecurity, ground transportation, freight, and logistics, and machinery.

Enterprise workflow software also sits squarely here. A market leader with deep customer integrations, high switching costs and defensible data moats has a structural advantage – but only if it treats AI as a board level priority and creates features customers will pay for.

Augmentation – the sector survives, leaders may not: in this cluster, with $1.3 trillion of profits at stake, Bain finds AI brings less dramatic changes to underlying business models while the critical question is who will win the race for AI-powered productivity gains. Companies that move more slowly to capture those gains will find that more aggressive competitors squeeze margins. Fast adopters in hospitality, for instance, could use AI to sharpen consumer insights, extend demand forecasting, dynamically adjust pricing, and sustain customer engagement beyond their next visit.

Revolution – delivery changes, the need doesn't: with $0.3 trillion of profits at stake, this cluster echoes the disruptions from the Internet as the sectors affected, such as customer support, IT services, and online tutoring and test prep, see their core product or service shift to AI or the margin for intermediaries disappears. Companies in these sectors face replacement of their entire delivery model. The profit pool does not disappear but migrates to whoever owns the AI layer.

Media contacts:

Dan Pinkney (Boston) – Email: [email protected]

Gary Duncan (London) – Email: [email protected]

Ann Lee (Singapore) – Email: [email protected]

About Bain & Company

Bain & Company works with leaders worldwide to solve their toughest challenges and deliver enduring results. Since 1973, we've partnered with clients, including private equity and portfolio companies, to build the capabilities they need to stay ahead of change and help them redefine their industries. We measure our success by our clients' success, and we proudly hold the highest levels of client advocacy in our field.

Bain is consistently recognized globally as one of the best places to work. We operate as one global team, uniting strategists, industry and functional experts, technologists, and advisors with a vibrant ecosystem of technology partners.

Notes to Editors

Bain & Company was founded in 1973 and today has 19,000 employees across 67 cities in 40 countries. We have worked with more than two-thirds of the Global 500 and more than 9,000 companies worldwide. Bain has pledged to deliver $2 billion in pro bono consulting to nonprofit, public-sector and charitable organizations by 2035. The firm is consistently recognized as a Leader in major analyst rankings across multiple areas, including digital business, innovation, strategy, experience design, customer experience, and carbon-zero transformation.

SOURCE Bain & Company

Share this article